tiprankstipranks
Enfusion (ENFN)
NYSE:ENFN
US Market
Holding ENFN?
Track your performance easily

Enfusion (ENFN) Technical Analysis

32 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
6Neutral
3Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Enfusion’s (ENFN) Moving Averages Convergence Divergence (MACD) indicator is 0.29, suggesting Enfusion is a Buy.
Enfusion’s (ENFN) 20-Day exponential moving average is 10.36, while Enfusion’s (ENFN) share price is $10.63, making it a Buy.
Enfusion’s (ENFN) 50-Day exponential moving average is 9.86, while Enfusion’s (ENFN) share price is $10.63, making it a Buy.

Enfusion (ENFN) Pivot Points

Dec 21, 2024, 05:44 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.81
10.11
10.29
10.59
10.77
11.07
11.25
Fibonacci
10.11
10.29
10.41
10.59
10.77
10.89
11.07
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Enfusion (ENFN) Moving Averages

Dec 21, 2024, 05:44 PM
Period
Simple
Exponential
MA5
10.70Sell
10.64Sell
MA10
10.63Buy
10.57Buy
MA20
10.37Buy
10.36Buy
MA50
9.68Buy
9.86Buy
MA100
9.10Buy
9.45Buy
MA200
9.11Buy
9.23Buy
Enfusion’s (ENFN) 10-Day exponential moving average is 10.57, while Enfusion’s (ENFN) share price is $10.63, making it a Buy.
Enfusion’s (ENFN) 100-Day exponential moving average is 9.45, while Enfusion’s (ENFN) share price is $10.63, making it a Buy.
Enfusion’s (ENFN) stock price is $10.63 and Enfusion’s (ENFN) 50-day simple moving average is 9.68, creating a Buy signal.
Enfusion’s (ENFN) stock price is $10.63 and Enfusion’s (ENFN) 100-day simple moving average is 9.10, creating a Buy signal.
Enfusion’s (ENFN) stock price is $10.63 and Enfusion’s (ENFN) 200-day simple moving average is 9.11, creating a Buy signal.

Enfusion (ENFN) Technical Indicators

Dec 21, 2024, 05:44 PM
Name
Value
Implied Action
RSI (14)
59.57
Neutral
STOCH (9,6)
37.33
Neutral
STOCHRSI (14)
47.82
Neutral
MACD (12,26)
0.29
Buy
ADX (14)
43.87
Neutral
Williams %R
-52.65
Buy
CCI (14)
42.06
Neutral
ATR (14)
0.36
-
Ultimate Oscillator
49.73
Neutral
ROC
4.83
Buy
Enfusion’s (ENFN) Relative Strength Index (RSI) is 59.57, creating a Neutral signal.
Enfusion’s (ENFN) Trend Strength Indicator (ADX) is 43.87, creating a Neutral signal.
Enfusion’s (ENFN) Commodity Channel Index (CCI) is 42.06, creating a Neutral signal.
Enfusion’s (ENFN) Price Rate of Change (ROC) is 4.83, creating a Buy signal.

FAQ

Is ENFN a Buy, Hold, or Sell?
Based on ENFN’s technical indicators, ENFN is a Buy.
    What is ENFN’s RSI (14)?
    ENFN’s RSI (14) is 59.57, which suggests ENFN is a Neutral.
      What is ENFN’s MACD?
      ENFN’s MACD is 0.29, which suggests ENFN is a Buy.
        What is ENFN’s 5-day moving average?
        ENFN’s 5-day moving average is 10.70, which suggests ENFN is a Sell.
          What is ENFN’s 20-day moving average?
          ENFN 20-day moving average is 10.37, which suggests ENFN is a Buy.
            What is ENFN’s 50-day moving average?
            ENFN’s 50-day moving average is 9.68, which suggests ENFN is a Buy.
              What is ENFN’s 200-day moving average?
              ENFN’s 200-day moving average is 9.11, which suggests ENFN is a Buy.
                What is ENFN’s Williams % R (14)?
                ENFN’s Williams % R (14) is -52.65, which suggests ENFN is a Buy.
                  What is ENFN’s CCI (14)?
                  ENFN’s CCI (14) is 42.06, which suggests ENFN is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis